Clinica
- JAMA, 23 marzo 2022 | “Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19”
- Annals of Internal Medicine , 1 marzo 2022 | “Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions”
- New England Journal of Medicine, 9 marzo 2022 | “Efficacy of Antiviral Agents against the SARS- CoV-2 Omicron Subvariant BA.2”
- JAMA, 24 febbraio 2022 | “Remote Patient Monitoring During COVID-19An Unexpected Patient Safety Benefit”
- New England Journal of Medicine, 16 febbraio 2022 | “Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection”
- JAMA, 7 febbraio 2022 | “Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications”
- JAMA , 26 gennaio 2026 | “COVID-19 and the Common Cold—Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity”
- JAMA, 24 gennaio 2022 | “Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19”
- JAMA, editoriale 24 gennaio 2022 | “Defining Optimal Respiratory Support for Patients With COVID-19”
- JAMA, 14 gennaio 2022 | “Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection”
- JAMA, 14 gennaio 2022 | “COVID-19 Therapeutics for Nonhospitalized Patients”
- JAMA, editoriale 14 gennaio 2022 | “Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management”
- The Lancet, 23 dicembre 2021 | “Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial”
- The Lancet, 23 dicembre 2021 | “Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19”
- JAMA Pediatrics, 21 dicembre 2021 | ” Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy”
- JAMA, 17 dicembre 2021 | ” Treating the Most Critically Ill Patients With COVID-19The Evolving Role of Extracorporeal Membrane Oxygenation”
- MMWR, 19 novembre 2021 | “Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — United States, March 2020–September 2021”
- JAMA, 29 ottobre 2021 | “Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction”
- JAMA, 29 ottobre editoriale | “Myocardial Infarction During the COVID-19 Pandemic”
- The Lancet Global Health, 27 ottobre 2021 | “Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial”
- The Lancet Global Health, 27 ottobre 2021 editoriale | “Fluvoxamine for outpatients with COVID-19: where do we stand?”
- JAMA, 21 ottobre 2021 | “Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe HypoxemiaThe COVID STEROID 2 Randomized Trial”
- JAMA, 21 ottobre editoriale | “Glucocorticoid Dose in COVID-19Lessons for Clinical Trials During a Pandemic”
- The Lancet Respiratory Medicine, 18 ottobre 2021 | “Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial”
- JAMA, 11 ottobre 2021 | “Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19The ACTIV-4B Randomized Clinical Trial”
- JAMA , editoriale 11 ottobre 2021 | “Antithrombotic Therapy for Outpatients With COVID-19Implications for Clinical Practice and Future Research”
- New England Journal of Medicine, 6 ottobre 2021 | “Myocarditis after Covid-19 Vaccination in a Large Health Care Organization”
- New England Journal of Medicine, 6 ottobre 2021 | “Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel”
- BMJ, 23 settembre 2021 | “Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis”
- MMWR, 31 agosto 2021 | “Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021”
- New England Journal of Medicine, 18 agosto 2021 | “Early Convalescent Plasma for High-Risk Outpatients with Covid-19”
- JAMA, 4 agosto 2021 | “Myocarditis and Pericarditis After Vaccination for COVID-19”
- The Lancet Digital Health, 22 luglio 2021 | “Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study”
- The Lancet, 17 luglio 2021 | “Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study”
- JAMA Cardiology, 29 giugno 2021 editoriale | “Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines”
- New England Journal of Medicine, 23 giugno 2021 | “Multisystem Inflammatory Syndrome in U.S. Children and Adolescents”
- The Lancet Infectious Disease, 22 giugno 2021 | “Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study”
- New England Journal of Medicine, 16 Giugno 2021 | “Treatment of Multisystem Inflammatory Syndrome in Children”
- New England Journal of Medicine, 16 giugno 2021 | “Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes”
- New England Journal of Medicine, 10 giugno 2021 | “Adjunct Immune Globulin for Vaccine- Induced Thrombotic Thrombocytopenia”
- The Lancet, 4 giugno 2021 | “Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open- label, multicentre, randomised, controlled trial”
- The Lancet Microbe, 2 giugno 2021 | “Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study”
- The Lancet Respiratory Medicine, 26 maggio 2021 | “COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion”
- ScienceDirect, 21 maggio 2021 | “Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India”
- BMJ, 20 maggio 2021 | ” Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries”
- The Lancet Respiratory Medicine, 14 maggio 2021 |“Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK”
- Nature Medicine, 5 maggio 2021 | “ Delayed production of neutralizing antibodies correlates with fatal COVID-19”
- JAMA, 30 aprile 2021 | “US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021”
- Jama, 30 aprile editoriale | “Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine”
- JAMA , 29 aprile 2021 | “Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes”
- JAMA Internal Medicine, 27 aprile 2021 | “Association of Facial Paralysis With mRNA COVID-19 Vaccines”
- JAMA, 23 aprile 2021 | “Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic”
- The Lancet Respiratory Medicine, 16 aprile 2021 | “Non-invasive respiratory support strategies in COVID-19”
- JAMA, 25 marzo 2021 | “Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory FailureThe HENIVOT Randomized Clinical Trial”
- JAMA, editoriale 25 marzo 2021 | “Respiratory Support During the COVID-19 PandemicIs It Time to Consider Using a Helmet?”
- JAMA, 18 marzo 2021 | “Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care UnitThe INSPIRATION Randomized Clinical TrialEfficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant”
- AMA, editoriale 18 marzo 2021 | ” Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19”
- The Lancet Child and Adolescent Health, 9 marzo 2021 | “Addressing fundamental questions on MIS-C”
- The Lancet Child and Adolescent Health, 9 marzo 2021 | “Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study”
- MMWR, 8 marzo 2021 | “Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020”
- Nature medicine, 2 marzo 2021 | “Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics”
- JAMA, 24 febbraio 2021 | “Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19”
- New England Journal of Medicine, 17 febbraio 2021 | “Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination”
- BMJ, 11 febbraio 2021 | “Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study”
- JAMA, 10 febbraio 2021 | “Researchers Investigate What COVID-19 Does to the Heart”
- Nature, 8 febbraio 2021 | “Signs of self-sustained inflammatory circuits in severe COVID pneumonia”
- Annals of Internal Medicine, 2 febbraio 2021 | “Clinical Decision Making During the COVID-19 Pandemic”
- Jama , 1 febbraio 2021 | “Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children”
- Science, 6 gennaio 2021 | “Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection”
- Cochrane Library, 6 gennaio 2021 | “Coronavirus (COVID-19): evidence relevant to clinical rehabilitation”
- New England Journal of Medicine, 11 dicembre 2020 | “Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19”
- JAMA, 23 novembre 2020 | “Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19”
- JAMA, 20 novembre 2020 | “Older Adults and the Mental Health Effects of COVID-19”
- JAMA, 18 novembre 2020 | “A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection”
- The Lancet Diabetes and Endocrinology , 23 dicembre 2020 | “Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland”
- MMWR , 13 novembre 2020 | “Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020”
- JAMA, 11 novembre 2020 | “Therapy for Early COVID-19- A Critical Need”
- The Lancet Respiratory Medicine , 23 ottobre 2020 | “Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study”
- The Lancet Respiratory Medicine, 8 ottobre 2020 | “Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study”
- JAMA, 5 ottobre 2020 | “Long-term Health Consequences of COVID-19”
- Morbidity Mortality Weekly Report (MMWR), 2 ottobre 2020 | “Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020”
- JAMA, 30 settembre 2020 | “COVID-19 and Heart Failure With Preserved Ejection Fraction”
- JAMA Network, 22/29 settembre 2020 | EDITORIALS
- JAMA Internal Medicine, 18 settembre 2020 | “Severe COVID-19 Infections—Knowledge Gained and Remaining Questions”
- Nature, 14 settembre 2020 | “The lasting misery of coronavirus long-haulers”
- Jama Internal Medicine, 9 settembre 2020 | “Clinical Outcomes in Young US Adults Hospitalized With COVID-19”
- JAMA Internal Medicine, 10 settembre 2020 | “Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia. A Randomized Clinical Trial”
- JAMA Internal Medicine, 10 settembre 2020 (editoriale) | “Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)—Beware of Blind Spots”
- JAMA, 11 settembre 2020 | “COVID-19 and the Path to Immunity”
- BMJ, 27 agosto 2020 | “Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study”
- The Lancet Respiratory Medicine, 27 agosto 2020 | “Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study”
- Clinical Infectious Diseases, 27 agosto 2020 | “Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19”
- JAMA, 19 agosto 2020 | “Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women”
- JAMA, 20 agosto 2020 | “What Happens When COVID-19 Collides With Flu Season?”
- Annals of Internal Medicine, 29 luglio 2020 | “Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection”
- New England Journal of Medicine, 6 agosto 2020 | “False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications”
- JAMA Internal Medicine, 18 agosto 2020 | “Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China”
- New England Journal of Medicine, 23 luglio 2020 | “Multisystem Inflammatory Syndrome in U.S. Children and Adolescents”
- JAMA Cardiology (editoriale), 27 luglio 2020 | “Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?”
- JAMA Cardiology, 27 luglio 2020 | “Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)”
- Annals of Internal Medicine, 17 luglio 2020 | “SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution”
- JAMA, 24 luglio 2020 (editoriale) | “Molecular Underpinnings of Severe Coronavirus Disease 2019”
- JAMA, 20 luglio 2020 | “Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System”
- The Lancet Diabetes & Endocrinology, 17 luglio 2020 | “COVID-19 in people with diabetes: understanding the reasons for worse outcomes”
- JAMA, 10 luglio 2020 | “Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) . A Review”
- The Lancet Haematology, 10 luglio 2020 | “Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study”
- The Lancet, 10 luglio 2020 | “An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19”
- New England Journal of Medicine, 9 luglio 2020 | “Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19”
- JAMA, 9 luglio 2020 | “Persistent Symptoms in Patients After Acute COVID-19”
- The Lancet Respiratory Medicine, 6 luglio 2020 | “COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?”
- The Lancet Neurology, 2 luglio 2020 | “Neurological associations of COVID-19”
- The Lancet Child & Adolescent Health, 2 luglio 2020 | “Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis”
- JAMA Internal Medicine, 30 giugno 2020 | “Is a “Cytokine Storm” Relevant to COVID-19?
- New England Journal of Medicine, 29 giugno2020 | “Multisystem Inflammatory Syndrome in U.S. Children and Adolescents”
- The Lancet Respiratory Medicine , 26 giugno 2020 | “Identification of pathophysiological patterns for triage and respiratory support in COVID-19”
- The Lancet Child & Adolescent Health, 25 giugno 2020 | “COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study”
- Nature, 24 giugno 2020 | “Mounting clues suggest the coronavirus might trigger diabetes”
- The Lancet Diabetes and Endocrinology, 20 giugno 2020 | “Association between high serum total cortisol concentrations and mortality from COVID-19”
- JAMA,19 giugno 2020 | “Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality”
- JAMA,19 giugno 2020, EDITORIALE
- European Heart Journal, 7 giugno 2020 | “COVID-19: from epidemiology to treatment”
- Annals of Internal Medicine, 4 giugno 2020 | “Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2”
- JAMA Pediatrics, 3 giugno 2020 | “Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York”
- JAMA, Editoriale, 3 giugno 2020 | “Children in the Eye of the Pandemic Storm – Lessons From New York City”
- Istituto Mario Negri, 1 giugno 2020 | ”Covid-19 e farmaci: aggiornamento su quelli usati in terapia”
- The Lancet, 29 maggio 2020 | ”Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study”
- The Lancet Respiratory Medicine, 29 maggio 2020 | “Lung function testing in the COVID-19 endemic”
- The Lancet Haematology, 1 giugno 2020 | “COVID-19 coagulopathy: an evolving story”
- Jama Neurology, 29 maggio 2020 | ”Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019A Review”
- The Lancet Psychiatry, 18 maggio 2020 | ”Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic”
- The Lancet, 14 maggio 2020 | “Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study”
- The Lancet, 14 maggio 2020 | ”An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study”
- New England Journal of Medicine, 13 maggio 2020 | “Multiorgan and Renal Tropism of SARS-CoV-2”
- JAMA Internal Medicine, 12 maggio 2020 | ”Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19”
- JAMA, 11 maggio 2020 | ”COVID-19 and Postinfection Immunity- Limited Evidence, Many Remaining Questions”
- JAMA, 6 maggio 2020 | “Interpreting Diagnostic Tests for SARS-CoV-2”
- Journal of Hematology, 5 maggio 2020 | “Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection”
- JAMA Cardiology, 1 maggio 2020 editoriale | “Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation”
- JAMA Cardiology, 1 maggio 2020 |”Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit”
- JAMA Cardiology, 1 maggio 2020 | “Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)”
- New England Journal of Medicine, 1 maggio 2020 [editoriale] | “Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19”
- New England Journal of Medicine , 1 maggio 2020 | “Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19”
- New England Journal of Medicine, 1 maggio 2020 | ”Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19”
- New England Journal of Medicine, 1 maggio 2020 | “Cardiovascular Disease, Drug – Therapy, and Mortality in Covid-19”
- The Journal of clinical investigation, 7 aprile 2020 | “Deployment of convalescent plasma for the prevention and treatment of COVID-19”
- Journal of Thrombosis and Thrombolysis, 27 aprile 2020 | ” Covid‑19 treatment update: follow the scientific evidence” [ evidenze sulla clorochina e idrossiclorochina]
- Lancet Diabetes Endocrinol, 23 aprile 2020 |”Practical recommendations for the management of diabetes in patients with COVID-19”
- Circulation, 16 aprile 2020 |”Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome”
- Annals of Internal Medicine, 13 aprile | “Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review”
- The Liverpool Drug Interaction Group, aggiornamento 9 aprile 2020 | “Detailed recommendations for interactions with experimental COVID-19 therapies” : drugs and interactions reviewed for known or possible QT/TdP risk”
- AIFA (Agenzia Italiana del Farmaco) 6 aprile 2020 | ” Sperimentazioni cliniche – COVID-19”
- AIFA (Agenzia Italiana del Farmaco), 2 aprile 2020 | “Schede informative sui farmaci utilizzati per emergenza COVID-19 e relative modalità di prescrizione”
- New Englan Journal of Medicine, 30 marzo 2020 |“Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19”
- JAMA Cardiology , 27 marzo 2020 | “Potential Effects of Coronaviruses on the Cardiovascular System. A Review”
- JAMA , 26 marzo 2020 | “ Management of Critically Ill Adults With COVID-19”
- CDC (U.S Centers for Disease Control and Prevention)- 22 marzo: “Information for Clinicians on Therapeutic Options for COVID-19 Patients”
- Documento OMS 13 marzo : “Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected.
- Società Italiana di Malattie Infettive e Tropicali (SIMIT) – Sezione regione Lombardia: 13 marzo 2020 il “ Vademecum per la cura delle persone con COVID-19”